New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News For MEDI;PFE;CELG;PRXL;ACOR;NPSP;ALKS;AZN;TEVA From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
<< 1 | 2 | 3 | 4 | 5 | 6 | 7 | all recent news | >>
April 27, 2015
14:41 EDTPFEEarnings Watch: Pfizer up over 6% since its last earnings report
Subscribe for More Information
12:47 EDTPFEPfizer technical comments before earnings
Subscribe for More Information
12:25 EDTTEVAOn The Fly: Top stock stories at midday
Subscribe for More Information
11:21 EDTTEVAMylan not going to sell without a fight, says BMO Capital
Subscribe for More Information
10:41 EDTTEVATeva reiterates commitment to acquisition for Mylan for $82 per share
Teva (TEVA) reiterated its commitment to its proposed combination with Mylan (MYL). As previously announced on April 21, 2015, Teva has proposed to acquire Mylan for $82.00 per share, with the consideration to be comprised of approximately 50% cash and 50% stock. Teva’s proposal for Mylan implies a total equity value of approximately $43B. Teva noted that the board and management team are committed to consummating a transaction as soon as possible. It continues to believe that the Teva proposal is "extremely attractive" for Myland stockholders, that owuld deliver more value than any other alternative. As previously announced, the transaction would not be subject to a financing condition or require a Teva stockholder vote. Teva’s proposal is contingent on Mylan not completing its proposed acquisition of Perrigo or any alternative transactions.
09:48 EDTTEVACNBC discusses Mylan patent challenges on Copaxone
Subscribe for More Information
09:22 EDTTEVAMylan board unanimously rejects expression of interest from Teva
Subscribe for More Information
09:20 EDTTEVAMylan board unanimously rejects expression of interest from Teva
09:03 EDTPFEChina Jo-Jo Drugstore signs incentive agreement with Pfizer subsidiary
China Jo-Jo Drugstores (CJJD) announced its subsidiary, Hangzhou Jiuzhou Grand Pharmacy Chain, has signed a new sales incentive agreement with Wyeth Pharmaceutical, a wholly owned subsidiary in China of Pfizer (PFE). The Agreement illustrated specific approaches and conditions of Jiuzhou Pharmacy's collaboration with Wyeth, including sales targets, promotional incentive to consumers, products and pricing methods. In return, Wyeth will fully support Jiuzhou Pharmacy with priority delivery, favorable purchase prices and promotional activities.
08:41 EDTPFE, AZNTelegraph discusses potential takeover of GSK by Pfizer
Subscribe for More Information
07:31 EDTCELGCelgene to acquire Quanticel Pharmaceuticals for $100M in cash
Subscribe for More Information
07:15 EDTTEVAMylan Perrigo offer makes Teva acquisition more likely, says Wells Fargo
After Mylan (MYL) announced its formal takeover offer for Perrigo (PRGO), Wells Fargo says that Mylan's lower than expected synergy guidance and the confirmation that Mylan shareholders will be required to approve the deal increase the chances that Teva will wind up buying Mylan. Wells continues to believe that Teva can significantly increase its bid for Mylan and that Mylan may have difficulty rejecting such an offer.
06:34 EDTTEVAOncoGenex subsidiary executes termination agreement with Teva
Subscribe for More Information
06:34 EDTTEVACiti says Teva, Mylan deal 'more likely than not'
Citigroup views a Teva (TEVA), Mylan (MYL) combination as "more likely than not" after Perrigo (PRGO) rejected Mylan's (MYL) second proposal to acquire the company. Citi believes investors are likely under appreciating how quickly a potential deal can be reached. It anticipates that the stichting set up by the Mylan board could trigger the call option to issue preference shares. Teva could appeal to the Dutch Enterprise Chamber, which Citi believes would likely constitute a "relatively speedy process." It has a Buy rating on Teva with a $70 price target.
06:33 EDTTEVAOncoGenex regains rights to custirsen executes termination agreement with Teva
Subscribe for More Information
06:19 EDTPFE, AZNPharmceutical companies buy drugs and raises prices, WSJ reports
Subscribe for More Information
April 26, 2015
12:50 EDTCELGApple, Celgene, others are 'top picks' for spring, Barron's says
In a survey of U.S. money managers, shares of Apple (AAPL), Dow Chemical (DOW), American Airlines (AAL), Celgene (CELG), General Motors (GM), and McDermott (MDR) were identified as top picks for this spring, Barron's contends in its cover story. Reference Link
April 24, 2015
16:31 EDTTEVAStocks finish week higher following strong tech earnings
Subscribe for More Information
12:02 EDTTEVAPerrigo plans to reject Mylan new offer, Bloomberg reports
Subscribe for More Information
10:59 EDTCELGCelgene call activity attributed to vague takeover speculation
Subscribe for More Information
<< 1 | 2 | 3 | 4 | 5 | 6 | 7 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use